Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial

P Peng Zhao Z Zhuo-Yu An H Hai-Xia Fu Y Yang Wang G Guo-Shuang Feng H Hui-Xin Liu D Dai-Hong Liu Y Yi Liu H He-Bing Zhou H Hui Liu Z Zhao Wang (State Key Laboratory of Bioinspired Interfacial Materials Science, State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials, Jiangsu Key Laboratory of Advanced Functional Polymer Materials, Suzhou Key Laboratory of Macromolecular Design and Precision Synthesis, College of Chemistry, Chemical Engineering and Materials Science) Y Yu-Jun Dong H Hong-Mei Jing Z Zhen-Ling Li L Li-Hong Li L Li-Ping Dou Q Qiu-Sha Huang J Jin Wu L Li-Ping Yang Y Yue Jin Z Zhi-Xue Li C Chen-Cong Wang Q Qi Chen X Xiao-Lu Zhu (The Key Laboratory of Mariculture, Ministry of Education, Fisheries College, Ocean University of China) Y Yun He (Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences) Y Yuan-Yuan Zhang (Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education, Department of Chemistry) Q Qian Jiang (State Key Laboratory of Loess Science, Institute of Earth Environment, Chinese Academy of Sciences) H Hao Jiang J Jin Lu (Center for Biological Physics, Arizona State University) Y Ying-Jun Chang X Xiang-Yu Zhao X Xiao-Jun Huang X Xiao-Hui Zhang